IFRX · InflaRx N.V.

Summary

InflaRx N.V. shareholders approved the adoption of 2025 annual accounts, re-appointed directors, extended share issuance authorizations, and amended articles of association.

Key takeaways

• Shareholders approved Dutch statutory annual accounts for FY2025, confirming financial results.
• KPMG Accountants N.V. appointed as external auditor for FY2026, ensuring audit continuity.
• Directors Niels Riedemann, Renfeng Guo, Nicolas Fulpius, Richard Brudnick, and Hege Hellstrom re-appointed.
• Board authorized to issue shares and limit pre-emption rights, providing capital flexibility.
• Articles of association amended to increase authorized share capital conditionally upon issuance.
• New Long-Term Incentive Plan (LTIP 2026) approved, aligning management with shareholder interests.